(ENX) Euronext - Overview
Exchange: PA •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0006294274
Stock:
Total Rating 47
Risk 77
Buy Signal 0.00
| Risk 5d forecast | |
|---|---|
| Volatility | 21.1% |
| Relative Tail Risk | -1.91% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.57 |
| Alpha | 13.44 |
| Character TTM | |
|---|---|
| Beta | 0.070 |
| Beta Downside | -0.055 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.70% |
| CAGR/Max DD | 1.20 |
EPS (Earnings per Share)
Revenue
Description: ENX Euronext
Euronext N.V., together with its subsidiaries, operates securities and derivatives exchanges in the Netherlands, France, Italy, Belgium, Portugal, Ireland, the United States, Norway, Denmark, and internationally. The company offers a range of exchange and corporate services, including security listings, cash and derivatives trading, and market data dissemination. It also provides listing venues and cash equities trading venues; and various marketplaces, including multilateral trading facilities for investors, broker-dealers, and other market participants to meet directly to buy and sell cash equities, fixed income securities, and exchange traded products. In addition, the company offers options contracts based on the blue-chip equities listed on Euronext; commodity derivatives, such as milling wheat futures contracts; and post-trade services, as well as distributes and sells real-time, historic, and reference data to data vendors, and financial institutions and individual investors. Further, it provides listing; cash, derivatives, fixed income, foreign exchange, and power trading; investor; advances data; clearing; custody and settlement; NTI; and other services. Additionally, it offers technology solutions and services to exchanges, venue operators, and financial institutions; colocation and network services; software and services licensed by third parties; and regulatory reporting services. The company was formerly known as Euronext Group N.V. and changed its name to Euronext N.V. in May 2014. Euronext N.V. was founded in 2000 and is headquartered in Amsterdam, the Netherlands.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 643.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.12 > 1.0 |
| NWC/Revenue: 92.75% < 20% (prev 56.49%; Δ 36.26% < -1%) |
| CFO/TA 0.00 > 3% & CFO 1.54b > Net Income 643.0m |
| Net Debt (1.87b) to EBITDA (1.17b): 1.60 < 3 |
| Current Ratio: 5.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (103.1m) vs 12m ago -0.92% < -2% |
| Gross Margin: 84.89% > 18% (prev 0.57%; Δ 8432 % > 0.5%) |
| Asset Turnover: 0.68% > 50% (prev 0.78%; Δ -0.10% > 0%) |
| Interest Coverage Ratio: 70.36 > 6 (EBITDA TTM 1.17b / Interest Expense TTM 13.8m) |
Altman Z''
| A: 0.01 (Total Current Assets 2.11b - Total Current Liabilities 421.2m) / Total Assets 327.63b |
| B: error (Retained Earnings missing) |
| C: 0.00 (EBIT TTM 972.1m / Avg Total Assets 268.51b) |
| D: 0.01 (Book Value of Equity 4.54b / Total Liabilities 322.90b) |
Beneish M 1.00
| DSRI: 0.98 (Receivables 450.5m/412.9m, Revenue 1.82b/1.63b) |
| GMI: 0.67 (GM 84.89% / 56.78%) |
| AQI: 32.05 (AQ_t 0.99 / AQ_t-1 0.03) |
| SGI: 1.12 (Revenue 1.82b / 1.63b) |
| TATA: -0.00 (NI 643.0m - CFO 1.54b) / TA 327.63b) |
| Beneish M-Score: 15.15 (Cap -4..+1) = D |
What is the price of ENX shares?
As of March 02, 2026, the stock is trading at EUR 140.00 with a total of 729,055 shares traded.
Over the past week, the price has changed by +9.03%, over one month by +18.04%, over three months by +7.78% and over the past year by +16.59%.
Over the past week, the price has changed by +9.03%, over one month by +18.04%, over three months by +7.78% and over the past year by +16.59%.
Is ENX a buy, sell or hold?
Euronext has no consensus analysts rating.
What are the forecasts/targets for the ENX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 147.3 | 5.2% |
| Analysts Target Price | - | - |
ENX Fundamental Data Overview March 01, 2026
Market Cap USD = 17.12b (14.52b EUR * 1.1794 EUR.USD)
P/E Trailing = 22.2576
P/E Forward = 17.8253
P/S = 7.981
P/B = 3.1384
P/EG = 2.4738
Revenue TTM = 1.82b EUR
EBIT TTM = 972.1m EUR
EBITDA TTM = 1.17b EUR
Long Term Debt = 2.91b EUR (from longTermDebt, last quarter)
Short Term Debt = 421.2m EUR (from shortTermDebt, last quarter)
Debt = 3.47b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.87b EUR (from netDebt column, last quarter)
Enterprise Value = 16.39b EUR (14.52b + Debt 3.47b - CCE 1.59b)
Interest Coverage Ratio = 70.36 (Ebit TTM 972.1m / Interest Expense TTM 13.8m)
EV/FCF = 23.05x (Enterprise Value 16.39b / FCF TTM 711.1m)
FCF Yield = 4.34% (FCF TTM 711.1m / Enterprise Value 16.39b)
FCF Margin = 39.10% (FCF TTM 711.1m / Revenue TTM 1.82b)
Net Margin = 35.36% (Net Income TTM 643.0m / Revenue TTM 1.82b)
Gross Margin = 84.89% ((Revenue TTM 1.82b - Cost of Revenue TTM 274.8m) / Revenue TTM)
Gross Margin QoQ = 88.12% (prev 88.75%)
Tobins Q-Ratio = 0.05 (Enterprise Value 16.39b / Total Assets 327.63b)
Interest Expense / Debt = 0.12% (Interest Expense 4.30m / Debt 3.47b)
Taxrate = 26.63% (56.8m / 213.3m)
NOPAT = 713.3m (EBIT 972.1m * (1 - 26.63%))
Current Ratio = 5.00 (Total Current Assets 2.11b / Total Current Liabilities 421.2m)
Debt / Equity = 0.76 (Debt 3.47b / totalStockholderEquity, last quarter 4.54b)
Debt / EBITDA = 1.60 (Net Debt 1.87b / EBITDA 1.17b)
Debt / FCF = 2.64 (Net Debt 1.87b / FCF TTM 711.1m)
Total Stockholder Equity = 4.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.24% (Net Income 643.0m / Total Assets 327.63b)
RoE = 14.94% (Net Income TTM 643.0m / Total Stockholder Equity 4.30b)
RoCE = 13.47% (EBIT 972.1m / Capital Employed (Equity 4.30b + L.T.Debt 2.91b))
RoIC = 9.64% (NOPAT 713.3m / Invested Capital 7.40b)
WACC = 5.00% (E(14.52b)/V(17.98b) * Re(6.17%) + D(3.47b)/V(17.98b) * Rd(0.12%) * (1-Tc(0.27)))
Discount Rate = 6.17% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.57%
[DCF] Terminal Value 87.39% ; FCFF base≈712.6m ; Y1≈798.7m ; Y5≈1.06b
[DCF] Fair Price = 289.3 (EV 31.30b - Net Debt 1.87b = Equity 29.43b / Shares 101.7m; r=5.90% [WACC]; 5y FCF grow 14.01% → 2.90% )
EPS Correlation: 69.57 | EPS CAGR: 3.47% | SUE: -0.20 | # QB: 0
Revenue Correlation: 80.16 | Revenue CAGR: 3.93% | SUE: 0.51 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.05 | Chg7d=-0.003 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=7.81 | Chg7d=+0.013 | Chg30d=+0.116 | Revisions Net=+2 | Growth EPS=+8.5% | Growth Revenue=+9.5%
EPS next Year (2027-12-31): EPS=8.48 | Chg7d=+0.068 | Chg30d=+0.114 | Revisions Net=+3 | Growth EPS=+8.5% | Growth Revenue=+4.5%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.5% (Discount Rate 7.9% - Earnings Yield 4.5%)
[Growth] Growth Spread = +4.8% (Analyst 8.2% - Implied 3.5%)
P/E Trailing = 22.2576
P/E Forward = 17.8253
P/S = 7.981
P/B = 3.1384
P/EG = 2.4738
Revenue TTM = 1.82b EUR
EBIT TTM = 972.1m EUR
EBITDA TTM = 1.17b EUR
Long Term Debt = 2.91b EUR (from longTermDebt, last quarter)
Short Term Debt = 421.2m EUR (from shortTermDebt, last quarter)
Debt = 3.47b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.87b EUR (from netDebt column, last quarter)
Enterprise Value = 16.39b EUR (14.52b + Debt 3.47b - CCE 1.59b)
Interest Coverage Ratio = 70.36 (Ebit TTM 972.1m / Interest Expense TTM 13.8m)
EV/FCF = 23.05x (Enterprise Value 16.39b / FCF TTM 711.1m)
FCF Yield = 4.34% (FCF TTM 711.1m / Enterprise Value 16.39b)
FCF Margin = 39.10% (FCF TTM 711.1m / Revenue TTM 1.82b)
Net Margin = 35.36% (Net Income TTM 643.0m / Revenue TTM 1.82b)
Gross Margin = 84.89% ((Revenue TTM 1.82b - Cost of Revenue TTM 274.8m) / Revenue TTM)
Gross Margin QoQ = 88.12% (prev 88.75%)
Tobins Q-Ratio = 0.05 (Enterprise Value 16.39b / Total Assets 327.63b)
Interest Expense / Debt = 0.12% (Interest Expense 4.30m / Debt 3.47b)
Taxrate = 26.63% (56.8m / 213.3m)
NOPAT = 713.3m (EBIT 972.1m * (1 - 26.63%))
Current Ratio = 5.00 (Total Current Assets 2.11b / Total Current Liabilities 421.2m)
Debt / Equity = 0.76 (Debt 3.47b / totalStockholderEquity, last quarter 4.54b)
Debt / EBITDA = 1.60 (Net Debt 1.87b / EBITDA 1.17b)
Debt / FCF = 2.64 (Net Debt 1.87b / FCF TTM 711.1m)
Total Stockholder Equity = 4.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.24% (Net Income 643.0m / Total Assets 327.63b)
RoE = 14.94% (Net Income TTM 643.0m / Total Stockholder Equity 4.30b)
RoCE = 13.47% (EBIT 972.1m / Capital Employed (Equity 4.30b + L.T.Debt 2.91b))
RoIC = 9.64% (NOPAT 713.3m / Invested Capital 7.40b)
WACC = 5.00% (E(14.52b)/V(17.98b) * Re(6.17%) + D(3.47b)/V(17.98b) * Rd(0.12%) * (1-Tc(0.27)))
Discount Rate = 6.17% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.57%
[DCF] Terminal Value 87.39% ; FCFF base≈712.6m ; Y1≈798.7m ; Y5≈1.06b
[DCF] Fair Price = 289.3 (EV 31.30b - Net Debt 1.87b = Equity 29.43b / Shares 101.7m; r=5.90% [WACC]; 5y FCF grow 14.01% → 2.90% )
EPS Correlation: 69.57 | EPS CAGR: 3.47% | SUE: -0.20 | # QB: 0
Revenue Correlation: 80.16 | Revenue CAGR: 3.93% | SUE: 0.51 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.05 | Chg7d=-0.003 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=7.81 | Chg7d=+0.013 | Chg30d=+0.116 | Revisions Net=+2 | Growth EPS=+8.5% | Growth Revenue=+9.5%
EPS next Year (2027-12-31): EPS=8.48 | Chg7d=+0.068 | Chg30d=+0.114 | Revisions Net=+3 | Growth EPS=+8.5% | Growth Revenue=+4.5%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.5% (Discount Rate 7.9% - Earnings Yield 4.5%)
[Growth] Growth Spread = +4.8% (Analyst 8.2% - Implied 3.5%)